Priorix: use extended in children

The licence for Priorix (combined measles, mumps and rubella vaccine) has been extended to include use in children aged 9 months or older.

Previously, Priorix was not recommended for use in children under 12 months of age

Further information: GlaxoSmithKline

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Topical Steroids, Comparison of Potencies and Formulations

Topical Steroids, Comparison of Potencies and Formulations

Strengths and formulations of topical steroids.

Topical Steroids, Potential Skin Sensitisers as Ingredients

Topical Steroids, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in topical steroids.

Correct vitamin D deficiency to reduce COPD exacerbations, say researchers

Correct vitamin D deficiency to reduce COPD exacerbations, say researchers

Vitamin D supplements could nearly halve the rate of...

Launch of new SGLT2 inhibitor increases choice in diabetes prescribing

Launch of new SGLT2 inhibitor increases choice in diabetes prescribing

Ertugliflozin (Steglatro) is a sodium glucose co-transporter...